On September 26, Aehr Test rose 8.19% in regular trading, trading at $105.29/share, with turnover of approximately $245 million. The rally was fueled by growing Wall Street optimism around AI-driven testing demand and a series of significant order wins.

On the news front, Oppenheimer recently initiated coverage of the stock with an Outperform rating and a $120 price target, noting that as AI chip power and packaging value increase, late-stage failure costs rise substantially, positioning Aehr Test for an AI-driven earnings inflection point. Analysts polled by FactSet assign the stock an average Buy rating with a mean price target of $127.

The company has secured a string of notable orders in recent months, including a $22 million follow-on production order from a core wafer-level AI processor customer and additional orders from a silicon photonics client. Its Sonoma platform received a record $41 million order. AI data center business now accounts for approximately 70% of revenue, marking a structural transformation from silicon carbide toward AI test solutions.

Within the Semiconductor Equipment sector, Applied Materials rose 2.4%, Lam Research rose 2.72%, ASML Holding rose 1.3%, KLA Corporation rose 0.48%, and AXT Inc rose 4.86%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)